ckd glp-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity Updates in Medicine | CKD

Targeted therapies in early stage NSCLC: hype or hope

Tosin urged patients to come prepared to share their full history

The BPC-157 programme was quietly dropped

Obesity is a chronic, relapsing disease influenced by genetics, hormones, metabolism, lifestyle and environmental factors

Additionally, environmental factors such as iodine excess or deficiency, smoking, stress, exposure to chemicals, medications (e.g., amiodarone, interferon-), and some viral/bacterial infections can alter gene expression patterns through epigenetic mechanisms and trigger autoimmune processes

With one in every eight American adults having already tried a GLP-1, its safe to assume that recent New Years resolutions will mean an onslaught of new prescriptions